Thrombomodulin 抗体
-
- 抗原 See all Thrombomodulin (THBD) 抗体
- Thrombomodulin (THBD)
-
适用
- 人
-
宿主
- 大鼠
-
克隆类型
- 单克隆
-
标记
- This Thrombomodulin antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Flow Cytometry (FACS), Functional Studies (Func)
- 交叉反应 （详细）
- Species reactivity (tested):Human
- 纯化方法
- Protein G
- 克隆位点
- RTM98
- 亚型
- IgG2a
- Top Product
- Discover our top product THBD Primary Antibody
-
anti-Thrombomodulin (THBD) (AA 69-194) antibody
THBD 适用: 人 WB, IHC, ELISA, Coat, ISt, StM 宿主: 小鼠 Monoclonal THBD-1591 unconjugated
anti-Thrombomodulin (THBD) (AA 200-500) antibodyTHBD 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Thrombomodulin (THBD) (AA 69-194) antibodyTHBD 适用: 人 IHC, ELISA, Coat, ISt, StM 宿主: 小鼠 Monoclonal THBD-1782 unconjugated
anti-Thrombomodulin (THBD) (AA 69-194) antibodyTHBD 适用: 人 IHC, ELISA, Coat, ISt, StM 宿主: 小鼠 Monoclonal rTHBD-1591 unconjugated Recombinant Antibody
anti-Thrombomodulin (THBD) (C-Term) antibodyTHBD 适用: 人, 大鼠, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Thrombomodulin (THBD) (C-Term) antibodyTHBD 适用: 人 WB, IP, IF, ICC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Thrombomodulin (THBD) (AA 297-505) antibodyTHBD 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 2C6C3 unconjugated
anti-Thrombomodulin (THBD) (AA 31-167) antibodyTHBD 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Thrombomodulin (THBD) (AA 324-480) antibodyTHBD 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Thrombomodulin (THBD) (AA 92-126) antibodyTHBD 适用: 人 WB, FACS, IF 宿主: 兔 Polyclonal RB56919 unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store at 2 - 8 °C.
-
- 抗原
- Thrombomodulin (THBD)
- 别名
- CD141 / THBD (THBD 产品)
- 背景
- The protein C anticoagulant pathway serves as a major system for controlling coagulation and limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. The essential components of the pathway involve thrombin, thrombomodulin, the endothelial cell protein C receptor (EPCR), protein C and protein S. Thrombomodulin binds thrombin, directly inhibiting its clotting and cell activation potential while at the same time augmenting protein C. The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-TM complex more than 10-fold. TM also accelerates thrombin activation of a plasma procarboxypeptidase B, named thrombin activatable fibrinolysis inhibitor or TAFI resulting in slowing clot lysis. The inhibited thrombin rapidly dissociates from thrombomodulin, regenerating the anticoagulant surface. Thrombomodulin also has direct anti-inflammatory activity, minimizing cytokine formation in the endothelium and decreasing leukocyte-endothelial cell adhesion. Thrombomodulin inhibits leukocyte binding to activated endothelium. TM has been detected in a variety of cells and tissues in adults and during development, including astrocytes in the brain, keratinocytes, endothelial cells, mesothelial cells of the peritoneum, and circulating neutrophils, monocytes, and platelets. During fetal development, TM plays a central role in controlling the growth and survival of trophoblast cells in the placenta, a function essential for the maintenance of pregnancy. Thrombin binding to thrombomodulin involves anion binding exosite 1 on thrombin and epidermal growth factor (EGF) domains 4 to 6 on thrombomodulin.Synonyms: Fetomodulin, THRM, Thrombomodulin
- UniProt
- P07204
-
